Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula: An Uncontrolled, Open-label, Descriptive Study

NCT02431377 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.

NCT NCT02431377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02431377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula: An Uncontrolled, Open-label, Descriptive Study
Lead sponsor
Société des Produits Nestlé (SPN)
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2015
Completion date
October 31, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infant formula intolerance